Client Alerts & Insights
CDC Provides Updated Recommendations on COVID-19 Quarantine and Isolation Times
December 28, 2021
On December 27, 2021, the Centers for Disease Control and Prevention (“CDC”) provided new guidance regarding its recommended times for quarantine and isolation for individuals exposed to COVID-19. Employers that have chosen to follow the CDC’s advisory guidance to date may consider revising their practices in light of the CDC’s update.
Isolation Timeframe Following Infection
Regardless of vaccination status, if any individual has a confirmed COVID-19 infection, the CDC encourages that individual to isolate for 5 days and, if asymptomatic at that time, the individual may leave isolation while continuing to wear a mask when around others for an additional 5 days. Individuals who have a fever 5 days after their infection was confirmed should continue to stay home until the fever resolves.
Quarantine Timeframes Following Exposure
Per the new guidance, individuals that were exposed to someone with COVID-19 and (a) are unvaccinated or (b) are vaccinated but more than 6 months removed from their second dose of the Pfizer or Moderna vaccines (or more than 2 months removed from their dose of the Johnson & Johnson vaccine) and are not boosted should quarantine for 5 days, followed by an additional 5 days of mask use when around others.
For individuals who have received booster doses of their respective vaccines, the CDC advises that, while quarantine is not necessary following an exposure, these individuals should nevertheless wear a mask for 10 days after exposure.
If quarantining is infeasible, the CDC strongly recommends that all exposed individuals wear a well-fitting mask at all times when around others for 10 days after exposure to mitigate COVID-19’s spread. Additionally, the CDC notes that it would be best practice to test for the virus 5 days after exposure and, if symptoms occur, to quarantine until a negative test confirms that the symptoms are not COVID-19 related.
Although the CDC’s guidance is advisory, employers should stay apprised of state or local rules that impose mandatory masking and/or vaccination requirements.
Please reach out to Benesch’s Labor & Employment Practice Group for more information.
Corey Clay at cclay@beneschlaw.com or 216.363.6196.
Latest News
The Coming State-Law Litigation Wave of 2026-27: “Subscription Trap” Class Actions
The subscription economy keeps growing—and so does the wave of class-action litigation targeting it. While the FTC’s regulatory efforts have drawn headlines, private class actions under state laws pose an even greater exposure risk.
Updates to Fees and Grace Periods for Nonimmigrant Visas
Starting September 9, 2026, the 9-11 Response Biometric Entry-Exit Fee will apply to H-1B and L-1 extension petitions filed by employers subject to the fee. Prior to the new rule, the fee was only required for (1) initial grant of status to a foreign national seeking H-1B or L-1 status and (2) a change of employer in the same status.
Third Circuit Decision Reshapes Creditor Standing in Successor Liability Disputes
The Third Circuit recently held that when determining whether a successor liability claim belongs to a bankruptcy estate, the key question is whether the claim seeks to remedy harm suffered by all creditors collectively or a unique injury suffered by a specific creditor. The fact that creditors may be permitted to bring the claim outside of bankruptcy is not, by itself, determinative.
CMS Proposes Sweeping Restrictions on Remote Patient Monitoring: The Outsourcing Ban, Reimbursement Revaluation and Potential Code Consolidation in the CY 2027 Physician Fee Schedule Proposed Rule
CMS’s CY 2027 Proposed Rule would significantly restrict Medicare reimbursement for Remote Patient Monitoring (RPM) and Remote Therapeutic Monitoring (RTM), including banning outsourced clinical staffing, adding new patient-relationship and initiating-visit requirements, reducing certain reimbursement rates, and exploring consolidation of existing billing codes.